Drug Shortage Report for CEFTIN
Report ID | 172335 |
Drug Identification Number | 02212307 |
Brand name | CEFTIN |
Common or Proper name | cefuroxime axetil for oral suspension |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | CEFUROXIME |
Strength(s) | 125MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 70ML |
ATC code | J01DC |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-10-19 |
Estimated end date | |
Actual end date | 2022-10-28 |
Shortage status | Resolved |
Updated date | 2022-11-04 |
Company comments | This product has been divested. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2022-11-04 | French | Compare |
v3 | 2022-11-04 | English | Compare |
v2 | 2022-10-21 | French | Compare |
v1 | 2022-10-21 | English | Compare |
Showing 1 to 4 of 4